Edition:
United Kingdom

People: Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

42.74USD
17 Jul 2019
Change (% chg)

$-0.11 (-0.26%)
Prev Close
$42.85
Open
$43.11
Day's High
$43.19
Day's Low
$42.73
Volume
3,883,404
Avg. Vol
6,603,732
52-wk High
$46.46
52-wk Low
$37.12

Blaylock, Ronald 

Mr. Ronald E. Blaylock is an Independent Director of Pfizer Inc. He is Founder, Managing Partner of GenNx360 Capital Partners, a private equity firm focused on investing in industrial and business services companies in the U.S. middle market, since 2006. Prior to launching GenNx360 Capital Partners, Mr. Blaylock founded and managed Blaylock & Company, an investment banking firm. Also held senior management positions at UBS, PaineWebber Group and Citicorp. Director of CarMax, Inc., Radio One, Inc. and W.R. Berkley, Inc., an insurance holding company. Director of Syncreon U.S., a for-profit private company. Member of the Board of Trustees of Carnegie Hall. Member of the Board of Overseers of New York University Stern School of Business. Member of the Board of Trustees of Prep for Prep, a not-for-profit organization.

Basic Compensation

Total Annual Compensation, USD 140,893
Restricted Stock Award, USD 192,500
Long-Term Incentive Plans, USD --
All Other, USD 30,000
Fiscal Year Total, USD 363,393

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ian Read

19,549,200

Albert Bourla

9,854,560

Frank D'Amelio

7,139,830

Mikael Dolsten

7,070,200

Michael Goettler

--

Angela Hwang

--
As Of  31 Dec 2018